These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26467296)

  • 1. Designing of the fixed-dose gastroretentive bilayer tablet for sustained release of metformin and immediate release of atorvastatin.
    Oh JH; Eun Lee J; Jeong Kim Y; Oh TO; Han S; Jeon EK; Shin K; Kim DH; Hye Park C; Lee YJ
    Drug Dev Ind Pharm; 2016; 42(2):340-9. PubMed ID: 26467296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects.
    Park SI; Lee H; Oh J; Lim KS; Jang IJ; Kim JA; Jung JH; Yu KS
    Drug Des Devel Ther; 2015; 9():729-36. PubMed ID: 25678778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of a fixed-dose combination of atorvastatin and metformin extended release versus concurrent administration of individual formulations: a randomized, open-label, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study.
    Kandhwal K; Dey S; Nazarudheen S; Arora R; Reyar S; Thudi NR; Monif T; Singh MK; Rao S
    Clin Drug Investig; 2011 Dec; 31(12):853-63. PubMed ID: 21919543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets.
    Ghim JL; Phuong NTT; Kim MJ; Kim EJ; Song GS; Ahn S; Shin JG; Kim EY
    Drug Des Devel Ther; 2019; 13():1623-1632. PubMed ID: 31190741
    [No Abstract]   [Full Text] [Related]  

  • 5. Gastro-floating bilayer tablets for the sustained release of metformin and immediate release of pioglitazone: preparation and in vitro/in vivo evaluation.
    He W; Li Y; Zhang R; Wu Z; Yin L
    Int J Pharm; 2014 Dec; 476(1-2):223-31. PubMed ID: 25283698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(3-4):167-84. PubMed ID: 23457958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilayer Tablet Formulation of Metformin HCl and Acarbose: A Novel Approach To Control Diabetes.
    Tiwari R; Gupta A; Joshi M; Tiwari G
    PDA J Pharm Sci Technol; 2014; 68(2):138-52. PubMed ID: 24668601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma scintigraphic evaluation of floating gastroretentive tablets of metformin HCl using a combination of three natural polymers in rabbits.
    Razavi M; Karimian H; Yeong CH; Chung LY; Nyamathulla S; Noordin MI
    Drug Des Devel Ther; 2015; 9():4373-86. PubMed ID: 26273196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic comparison of a new sustained-release formulation of glimepiride/metformin 1/500 mg combination tablet and a sustained-release formulation of glimepiride/metformin 2/500 mg combination tablet in healthy Korean male volunteers: a randomized, 2-sequence, 2-period, 2-treatment crossover study.
    Shin KH; Kim SE; Yoon SH; Cho JY; Jang IJ; Shin SG; Yu KS
    Clin Ther; 2011 Nov; 33(11):1809-18. PubMed ID: 22036245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steady-state pharmacokinetics of a novel extended-release metformin formulation.
    Timmins P; Donahue S; Meeker J; Marathe P
    Clin Pharmacokinet; 2005; 44(7):721-9. PubMed ID: 15966755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active coating of immediate-release evogliptin tartrate to prepare fixed dose combination tablet with sustained-release metformin HCl.
    Han Won D; Park H; Seo JW; Woo Jang S; Ha ES; Kim MS
    Int J Pharm; 2022 Jul; 623():121927. PubMed ID: 35716979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Pharmacokinetics of a Fixed-Dose Combination of Rosuvastatin/Metformin Sustained-Release (10/1000 mg) and Separate Tablets in Healthy Male Subjects.
    Huh KY; Kim E; Lee H; Jeon I; Suh H; Lee J; Lee Y; Yu KS; Lee S
    Clin Pharmacol Drug Dev; 2021 Feb; 10(2):207-213. PubMed ID: 32579298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilayer tablets of atorvastatin calcium and nicotinic acid: formulation and evaluation.
    Nirmal J; Saisivam S; Peddanna C; Muralidharan S; Godwinkumar S; Nagarajan M
    Chem Pharm Bull (Tokyo); 2008 Oct; 56(10):1455-8. PubMed ID: 18827389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and in vitro studies of a fixed-dose combination of a bilayer matrix tablet containing metformin HCl as sustained release and glipizide as immediate release.
    Mandal U; Pal TK
    Drug Dev Ind Pharm; 2008 Mar; 34(3):305-13. PubMed ID: 18363146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Formulation by design of experiments of immediate release tablets with metformin hydrochloride and glibenclamide].
    Potur RG; Gafiţanu E
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1219-26. PubMed ID: 21500483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD; Liu Y; Tang X; Zhang Q
    Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of food on the pharmacokinetics of gemigliptin/metformin sustained-release 50/1,000 mg (25/500 mg x 2 tablets) fixeddose combination tablet in healthy male volunteers.
    Choi HY; Noh YH; Kim YH; Kim MJ; Lee SH; Kim JA; Kim B; Lim HS; Bae KS
    Int J Clin Pharmacol Ther; 2014 May; 52(5):381-91. PubMed ID: 24495314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet.
    Qin C; He W; Zhu C; Wu M; Jin Z; Zhang Q; Wang G; Yin L
    Int J Pharm; 2014 May; 466(1-2):276-85. PubMed ID: 24607209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of in vivo bioavailability in beagle dogs of bilayer tablet consisting of immediate release nanosuspension and sustained release layers of rebamipide.
    Jin G; Ngo HV; Wang J; Cui JH; Cao QR; Park C; Jung M; Lee BJ
    Int J Pharm; 2022 May; 619():121718. PubMed ID: 35381311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.